Bill Text: IL HB5505 | 2023-2024 | 103rd General Assembly | Introduced
Bill Title: Amends the Pharmacy Practice Act. Provides that a pharmacy shall notify each person to whom a prescription drug is dispensed that an accessible prescription label is available to the person upon request at no additional cost. Provides that if a person informs the pharmacy that the person is blind, visually impaired, or otherwise print disabled, then the pharmacy shall provide to the person an accessible prescription label affixed to the bottle and the conditions of that label. Provides that a pharmacy shall ensure that a prescription label is compatible with the prescription reader if a prescription reader is provided. Provides that the provisions do not apply to prescription drugs dispensed or administered by an institutional pharmacy or correctional institution. Provides that the Department of Financial and Professional Regulation shall adopt rules to implement these provisions.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2024-04-05 - Rule 19(a) / Re-referred to Rules Committee [HB5505 Detail]
Download: Illinois-2023-HB5505-Introduced.html
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning regulation.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois, | |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Pharmacy Practice Act is amended by adding | |||||||||||||||||||
5 | Section 15.15 as follows:
| |||||||||||||||||||
6 | (225 ILCS 85/15.15 new) | |||||||||||||||||||
7 | Sec. 15.15. Accessible prescription labels. | |||||||||||||||||||
8 | (a) As used in this Section: | |||||||||||||||||||
9 | "Prescription reader" means a device that is designed to | |||||||||||||||||||
10 | audibly convey the information contained on the label of a | |||||||||||||||||||
11 | prescription drug. | |||||||||||||||||||
12 | "Institutional pharmacy" means a pharmacy that is part of | |||||||||||||||||||
13 | or is operated in conjunction with any of the following health | |||||||||||||||||||
14 | care facilities: hospital, ambulatory surgical facility, | |||||||||||||||||||
15 | nursing home, residential care facility, freestanding | |||||||||||||||||||
16 | rehabilitation facility, hospice care program, home and | |||||||||||||||||||
17 | community-based service provider, residential facility for | |||||||||||||||||||
18 | individuals with mental illness or developmental disabilities, | |||||||||||||||||||
19 | or any similar health care facility. | |||||||||||||||||||
20 | (b) A pharmacy shall notify each person to whom a | |||||||||||||||||||
21 | prescription drug is dispensed that an accessible prescription | |||||||||||||||||||
22 | label is available to the person upon request at no additional | |||||||||||||||||||
23 | cost. |
| |||||||
| |||||||